RenovoRx, Inc. Research and Development Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- RenovoRx, Inc. research and development expense for the quarter ending 2026-06-30 was $1.20M, a 15.85% decline year-over-year.
- RenovoRx, Inc. research and development expense for the quarter ending 2026-03-31 was $1.23M, a 25.21% decline year-over-year.
- RenovoRx, Inc. research and development expense for the quarter ending 2025-12-31 was $1.50M, a 4.76% decline year-over-year.
- RenovoRx, Inc. research and development expense for the quarter ending 2025-09-30 was $1.69M, a 2.12% increase year-over-year.
- RenovoRx, Inc. research and development expense for fiscal 2025 was $6.27M, a 4.05% increase from fiscal 2024.
- RenovoRx, Inc. research and development expense for fiscal 2024 was $6.03M, a 6.32% increase from fiscal 2023.
- RenovoRx, Inc. research and development expense for fiscal 2023 was $5.67M, a 31.76% increase from fiscal 2022.
- RenovoRx, Inc. research and development expense for fiscal 2022 was $4.30M, a 41.53% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.20M 10-Q · filed 2026-08-13 | $2.43M 10-Q · filed 2026-08-13 | $3.93M derived: sum of 3 quarters · filed 2026-08-13 | $5.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.23M 10-Q · filed 2026-05-14 | $2.73M derived: sum of 2 quarters · filed 2026-05-14 | $4.41M derived: sum of 3 quarters · filed 2026-05-14 | $5.84M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.19M derived: sum of 2 quarters · filed 2026-03-30 | $4.61M derived: sum of 3 quarters · filed 2026-08-13 | $6.27M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.69M 10-Q · filed 2025-11-13 | $3.11M derived: sum of 2 quarters · filed 2026-08-13 | $4.77M 10-Q · filed 2025-11-13 | $6.33M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.43M 10-Q · filed 2026-08-13 | $3.07M 10-Q · filed 2026-08-13 | $4.64M derived: sum of 3 quarters · filed 2026-08-13 | $6.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.64M 10-Q · filed 2026-05-14 | $3.22M derived: sum of 2 quarters · filed 2026-05-14 | $4.87M derived: sum of 3 quarters · filed 2026-05-14 | $6.41M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.23M derived: sum of 2 quarters · filed 2026-03-30 | $4.77M derived: sum of 3 quarters · filed 2026-03-30 | $6.03M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-13 | $3.19M derived: sum of 2 quarters · filed 2025-11-13 | $4.45M 10-Q · filed 2025-11-13 | $5.22M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.54M 10-Q · filed 2025-08-14 | $2.80M 10-Q · filed 2025-08-14 | $3.57M derived: sum of 3 quarters · filed 2025-08-14 | $5.20M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.26M 10-Q · filed 2025-05-15 | $2.03M derived: sum of 2 quarters · filed 2025-05-15 | $3.66M derived: sum of 3 quarters · filed 2025-05-15 | $5.59M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $2.40M derived: sum of 2 quarters · filed 2025-04-01 | $4.33M derived: sum of 3 quarters · filed 2025-04-01 | $5.67M 10-K · filed 2025-04-01 |
| 2023-09-30 | $1.63M 10-Q · filed 2024-11-13 | $3.55M derived: sum of 2 quarters · filed 2024-11-13 | $4.89M 10-Q · filed 2024-11-13 | $5.67M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.93M 10-Q · filed 2024-08-13 | $3.26M 10-Q · filed 2024-08-13 | $4.04M derived: sum of 3 quarters · filed 2024-08-13 | $4.88M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.34M 10-Q · filed 2024-05-10 | $2.11M derived: sum of 2 quarters · filed 2024-05-10 | $2.96M derived: sum of 3 quarters · filed 2024-05-10 | $4.35M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $776.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.62M derived: sum of 2 quarters · filed 2024-04-01 | $3.01M derived: sum of 3 quarters · filed 2024-04-01 | $4.30M 10-K · filed 2024-04-01 |
| 2022-09-30 | $846.00K 10-Q · filed 2023-11-13 | $2.24M derived: sum of 2 quarters · filed 2023-11-13 | $3.52M 10-Q · filed 2023-11-13 | $4.63M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.39M 10-Q · filed 2023-08-16 | $2.68M 10-Q · filed 2023-08-16 | $3.78M derived: sum of 3 quarters · filed 2023-08-16 | $4.55M derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | $1.29M 10-Q · filed 2023-05-12 | $2.39M derived: sum of 2 quarters · filed 2023-05-12 | $3.16M derived: sum of 3 quarters · filed 2023-05-12 | $3.69M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.87M derived: sum of 2 quarters · filed 2023-03-31 | $2.40M derived: sum of 3 quarters · filed 2023-03-31 | $3.04M 10-K · filed 2023-03-31 |
| 2021-09-30 | $767.00K 10-Q · filed 2022-11-14 | $1.30M derived: sum of 2 quarters · filed 2022-11-14 | $1.94M 10-Q · filed 2022-11-14 | $2.39M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $536.00K 10-Q · filed 2022-08-12 | $1.17M 10-Q · filed 2022-08-12 | $1.62M derived: sum of 3 quarters · filed 2022-08-12 | $2.35M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $635.00K 10-Q · filed 2022-05-13 | $1.09M derived: sum of 2 quarters · filed 2022-05-13 | $1.81M derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | $452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.18M derived: sum of 2 quarters · filed 2022-03-30 | $2.39M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $727.00K 10-Q · filed 2021-11-15 | $1.93M 10-Q · filed 2021-11-15 |